NOTV Stock Analysis: Buy, Sell, or Hold?
NOTV - Inotiv, Inc. Common Stock
$0.17
0.08 (91.80%)
β²
5d:
-41.92%
30d:
-44.56%
90d:
-55.0%
HOLD
MODERATE Confidence
Analysis Updated: Jun 5, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When NOTV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π HOLD: NOTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
π HOLD: NOTV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NOTV is currently trading at $0.17, which is considered oversold relative to its 30-day fair value range of $0.22 to $0.32.
Technical Outlook: Technically, NOTV is in a downtrend. Immediate support is located at $0.10, while resistance sits at $0.32. The stock is showing strong short-term momentum, up 91.8% recently.
Market Sentiment: NOTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+1856.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NOTV is in a downtrend. Immediate support is located at $0.10, while resistance sits at $0.32. The stock is showing strong short-term momentum, up 91.8% recently.
Market Sentiment: NOTV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+1856.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.22 -
$0.32
Company Quality Score
42/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Strong upward momentum (+91.8%)
- BULLISH: Trading 1856.7% below Wall St target ($3.25)
- CAUTION: 5-day price weakness (-41.9%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.22 -
$0.32
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.10
Resistance Level
$0.32
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.09
Wall Street Target
$3.25
(+1856.7%)
Revenue Growth (YoY)
-5.4%
Profit Margin
-17.1%
Share & Embed Analysis
Last updated: June 06, 2026 2:47 PM ET
Data refreshes hourly during market hours. Next update: 3:47 PM
Data refreshes hourly during market hours. Next update: 3:47 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NOTV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Beth A Taylor
SELL
2888 shares
2026-02-17
John E Sagartz
SELL
2119 shares
2026-02-17
Robert Jr. Leasure
SELL
16810 shares
2026-02-17
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific⦠|
STRONG BUY
31 analysts |
$612 | 58 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 65 BUY |
|
EXAS
EXACT Sciences Corporati⦠|
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 61 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 63 BUY |